Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 15;15:577–588. doi: 10.2147/DDDT.S291865

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Xu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The effects of quercetin combined with cisplatin on the P-Gp and METTL3 protein expression in cervical cancer cells. Western blot was used for the detection of MMP2 after drug treatment in HeLa (A) and SiHa cells (B), the detection of ezrin in HeLa (C) and SiHa (D), the detection of P-Gp in HeLa (E) and SiHa cells (F) and the detection of METTL3 in HeLa (G) and SiHa cells (H). The bar graphs represent the ratios of MMP2, ezrin, P-Gp and METTL3 relative expressions compared with internal parameter in HeLa and SiHa cells (I–P). Data are expressed as means ± SD deviation of three independent experiments. *P < 0.05 vs control group, ^#P < 0.05 vs cisplatin group.